
OpenEvidence Declines $20B Valuation Round, Eyes Acquisition
OpenEvidence, an AI chatbot startup that helps doctors access medical information, has fielded investor offers valuing the company at around $20 billion for a potential $200 million funding round. The company is unlikely to proceed with the raise due to shareholder dilution concerns and is simultaneously exploring acquisition discussions with a large tech company.


















